Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain

Int J Biochem Cell Biol. 2019 Sep:114:105558. doi: 10.1016/j.biocel.2019.06.006. Epub 2019 Jun 22.

Abstract

The figure describes the location of UHRF1 (Ubiquitin-like with containing PHD and RING Finger domains 1) gene, mRNA and protein synthesis in the tumor cell and its structural domains with a focus on the docking of Naphthazarin on the SRA domain of UHRF1, resulting in reduction of tumor size.

Keywords: Cancer; SRA domain; UHRF1; Universal oncogene.

Publication types

  • Review

MeSH terms

  • Animals
  • CCAAT-Enhancer-Binding Proteins* / chemistry
  • CCAAT-Enhancer-Binding Proteins* / genetics
  • CCAAT-Enhancer-Binding Proteins* / metabolism
  • Humans
  • Molecular Docking Simulation*
  • Neoplasm Proteins* / chemistry
  • Neoplasm Proteins* / genetics
  • Neoplasm Proteins* / metabolism
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Protein Domains
  • Ubiquitin-Protein Ligases* / chemistry
  • Ubiquitin-Protein Ligases* / genetics
  • Ubiquitin-Protein Ligases* / metabolism

Substances

  • CCAAT-Enhancer-Binding Proteins
  • Neoplasm Proteins
  • UHRF1 protein, human
  • Ubiquitin-Protein Ligases